Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
A common denominator among the multiple damage-inducing agents that ultimately lead to activation of NLRP3 has not yet been identified. Recently, production of reactive oxygen species (ROS) has been suggested to act as a common event upstream of the NLRP3 inflammasome machinery. Because de novo translation of NLRP3 is an essential step in the activation of NLRP3, we investigated the role of substances that inhibit either ROS production or its oxidative activity. Although we observe that NLRP3 inflammasome activation is unique among other known inflammasomes in its sensitivity to ROS inhibition, we have found that this phenomenon is attributable to the fact that NLRP3 strictly requires priming by a proinflammatory signal, a step that is blocked by ROS inhibitors. Although these data do not exclude a general role for ROS production in the process of NLRP3-triggered inflammation, they would put ROS upstream of NLRP3 induction, but not activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, these toxins mediate increased ROS production, which activates intrinsic apoptotic pathways and the NLRP3 inflammasome, thereby inflicting cytotoxicity in keratinocytes, neutrophils, and other tissue cells [14].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“Owing to the highly proinflammatory potential of bioactive IL-1b, its release is a tightly controlled process, in which caspase-1–mediated cleavage of pro–IL-1b is a rate-limiting step (1).”
BackgroundCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 1×
“To this effect, it has also been demonstrated that inhibitors of mitochondrial ROS production (17) and the knocking down of mitochondrial respiration by targeting the expression of voltage-dependent anion channels (18) downmodulate NLRP3-mediated inflammasome activation.”
BackgroundBauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959 · cited 4×
“Macrophages stably overexpressing NLRP3 were obtained through lentiviral transduction, as explained earlier (10).”
BackgroundMethodSelf-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationAIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Cited by
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
The NLRP3 Inflammasome: an overview of mechanisms of activation and regulation
Kelley, N., Jeltema, D., Duan, Y., & He, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133328 · Cited by 3,539
“At least one study reported that ROS inhibitors also block the priming signal for NLRP3 inflammasome activation [100].”
BackgroundActivation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Self-citationMechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759
“At least one study showed that ROS inhibitors also affect the induction of NLRP3 at the priming stage when used at high concentrations [49].”
BackgroundSelf-citationMechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
“A single unifying event has not emerged because some of these events do not occur with all Nlrp3-activating agents, or they are associated with multiple inflammasomes, or their occurrence is contested (Bauernfeind et al., 2011; Muñoz-Planillo et al., 2013; Pétrilli et al., 2007).”
BackgroundMuñoz-Planillo, R., Kuffa, P., Martínez-Colón, G., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,147
Self-citationLampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E. E., Loginicheva, E., Cervantes-Barragan, L., Ma, X., Huang, S. C.-C., Griss, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.004 · Cited by 1,541
“As interfering with mROS can affect inflammasome priming (Bauernfeind et al., 2011), the blunted mROS response mechanistically links Sdh inhibition and the anti-inflammatory effects of itaconate on IL-1b and IL-18 production (Figure 1G).”
BackgroundMolecular mechanisms regulating NLRP3 inflammasome activation
Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.95 · Cited by 1,378
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,269
Reactive oxygen species and mitochondria: A nexus of cellular homeostasis
Dan Dunn, J., Alvarez, L. A., Zhang, X., & Soldati, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.005 · Cited by 1,203
Regulation of inflammasome activation
Man, S. M., & Kanneganti, T. (2015) · Immunological Reviews · doi:10.1111/imr.12296 · Cited by 1,064
“A number of studies argued that mitochondrial perturbation, ROS, formation of large membrane pores and cell volume fluctuation are not required for the activation of the canonical NLRP3 inflammasome (53, 61, 62).”
BackgroundMitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,026
Sensing and reacting to microbes through the inflammasomes
Franchi, L., Muñoz-Planillo, R., & Núñez, G. (2012) · Nature Immunology · doi:10.1038/ni.2231 · Cited by 1,012
Self-citationNADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
“In the AD brain and diabetic pancreas, amyloid plaques arise from the aggregation of pre-fibrillar amyloidogenic peptides such as the Aβ(1-42) peptide17, 18, 19 or IAPP20, 21, 22, which oligomerize and give rise to higher order structures, including fibrils.”
BackgroundInflammasomes and Their Roles in Health and Disease
Lamkanfi, M., & Dixit, V. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155745 · Cited by 935
“Inflammasome components such as NLRP3, caspase-11, and proIL-1β are expressed at relatively low levels, and priming with NFκB-activating inflammatory cytokines, TLR ligands, and other PAMPs is required for their mRNAs to be induced (Bauernfeind et al. 2011, Bulua et al. 2011, Kayagaki et al. 2011).”
BackgroundROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., Sadler, J. J., Knepper-Adrian, V., Han, R., Qiao, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.001 · Cited by 931
“A recent study suggests that treatment with ROS inhibitors blocks priming of the Nlrp3 inflammasome (Bauernfeind et al., 2011); in order to specifically examine the effects of ROS on activation rather than priming of the Nlrp3 inflammasome, we treated cells with DPI, NAC, or APDC after LPS priming…”
MethodRedox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
“This leads to arguments of whether ROS are truly involved in the activation of NLRP3 inflammasomes, but instead are derived from TLRs and contribute to the priming mechanism (14).”
Li, X., Fang, P., Mai, J., Choi, E. T., Wang, H., & Yang, X.-F. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-19 · Cited by 812
“Indeed, this idea is challenged by the observation that ROS inhibitors block priming instead of activation of the NLRP3 inflammasome [94].”
BackgroundNon-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Juliana, C., Fernandes-Alnemri, T., Kang, S., Farias, A., Qin, F., & Alnemri, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407130 · Cited by 773
“Consistent with the previous study (12), NAC had no effect on NLRP3 activation inNG5 cells, which express up-regulated levels of NLRP3, in response to ATP (Fig.”
BackgroundResultNovel role of PKR in inflammasome activation and HMGB1 release
Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdes-Ferrer, S. I., Olofsson, P. S., Kalb, T., Roth, J., et al. (2012) · Nature · doi:10.1038/nature11290 · Cited by 757
The role of oxidative stress during inflammatory processes
Lugrin, J., Rosenblatt-Velin, N., Parapanov, R., & Liaudet, L. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 737
Mechanism of NLRP3 inflammasome activation
Sutterwala, F. S., Haasken, S., & Cassel, S. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12458 · Cited by 736
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Chen, J., & Chen, Z. J. (2018) · Nature · doi:10.1038/s41586-018-0761-3 · Cited by 692
The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation
Subramanian, N., Natarajan, K., Clatworthy, M. R., Wang, Z., & Germain, R. N. (2013) · Cell · doi:10.1016/j.cell.2013.02.054 · Cited by 678
“…source of ROS and oxidized DNA required for NLRP3 activation (Nakahira et al., 2011; Shimada et al., 2012; Zhou et al., 2011); others indicate that ROS production is required for priming and transcriptional induction of NLRP3 expression, but not for NLRP3 activation (Bauernfeind et al., 2011).”
Tan, H.-Y., Wang, N., Li, S., Hong, M., Wang, X., & Feng, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2795090 · Cited by 657
“in inflammasome activation is far more complicated as postulated and studies reported on caspase-8-dependent inflammasome activation and ROS-induced NLRP3 inflammasome priming have been further proposed recently [118, 119].”
BackgroundMetabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Yun, J., & Finkel, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.011 · Cited by 626
“Mitochondrial ROS plays an important role in inflammasome activation, although the precise target remains unidentified (Bauernfeind et al., 2011; Zhou et al., 2011).”
BackgroundXie, X., Deng, T., Duan, J., Xie, J., Yuan, J., & Chen, M. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.110133 · Cited by 619
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
Tarallo, V., Hirano, Y., Gelfand, B. D., Dridi, S., Kerur, N., Kim, Y., Cho, W. G., Kaneko, H., Fowler, B. J., Bogdanovich, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.036 · Cited by 592
“To determine how Alu RNA primed the inflammasome, we studied whether it induced reactive oxygen species (ROS) production, a signal for priming (Bauernfeind et al., 2011; Nakahira et al., 2011).”
Self-citationBlevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Williams, N. C., & O’Neill, L. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00141 · Cited by 570
“DMI also impaired production of ROS, NO, IL1β, IL18, and IL6.”
BackgroundInfluentialA sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion
Birchenough, G. M. H., Nyström, E. E. L., Johansson, M. E. V., & Hansson, G. C. (2016) · Science · doi:10.1126/science.aaf7419 · Cited by 568
NLRP3 inflammasome activity is negatively controlled by miR-223
Bauernfeind, F., Rieger, A., Schildberg, F. A., Knolle, P. A., Schmid-Burgk, J. L., & Hornung, V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201516 · Cited by 544
“whereas other inflammasome sensors, such as AIM2 or NLRC4, are sufficiently expressed under resting conditions (5).”
BackgroundSelf-citationGBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals
Shenoy, A. R., Wellington, D. A., Kumar, P., Kassa, H., Booth, C. J., Cresswell, P., & MacMicking, J. D. (2012) · Science · doi:10.1126/science.1217141 · Cited by 522
Inflammasomes in liver diseases
Szabo, G., & Csak, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.035 · Cited by 495
“AIM2 can directly bind to its ligand [32] and may contribute to the pathogenesis of autoimmune diseases by recognizing the mammalian DNA [49].”
BackgroundInfluentialInhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation
Vince, J. E., Wong, W. W.-L., Gentle, I., Lawlor, K. E., Allam, R., O'Reilly, L., Mason, K., Gross, O., Ma, S., Guarda, G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.012 · Cited by 491
“However, antioxidants commonly used to inhibit ROS accumulation can impair LPS induction of IL-1b precursor and NLRP3 (Bauernfeind et al., 2011; van de Veerdonk et al., 2010) and is consistent with a role for ROS in LPS transcriptional responses (Figures S4A–S4D; Gloire et al., 2006).”
BackgroundReactive oxygen species at the crossroads of inflammasome and inflammation
Harijith, A., Ebenezer, D. L., & Natarajan, V. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00352 · Cited by 476
“Moreover, pre-treatment of cells with antioxidants inhibits NLRP3/NALP3 inflammasome activation, suggesting a potential role for oxidative stress/redox signaling in NLRP3/NALP3 activation (Bauernfeind et al., 2011; Hua et al., 2013).”
BackgroundThe role of mitochondria in NLRP3 inflammasome activation
Liu, Q., Zhang, D., Hu, D., Zhou, X., & Zhou, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.010 · Cited by 475
Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal
Mills, E. L., & O'Neill, L. A. (2016) · European Journal of Immunology · doi:10.1002/eji.201445427 · Cited by 458
A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?
Wen, H., Ting, J. P.-Y., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2228 · Cited by 457
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease
Wang, S., Yuan, Y.-H., Chen, N.-H., & Wang, H.-B. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 444
Recognition of Bacteria by Inflammasomes
von Moltke, J., Ayres, J. S., Kofoed, E. M., Chavarría-Smith, J., & Vance, R. E. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095944 · Cited by 421
Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway
Evavold, C. L., Hafner-Bratkovič, I., Devant, P., D’Andrea, J. M., Ngwa, E. M., Boršić, E., Doench, J. G., LaFleur, M. W., Sharpe, A. H., Thiagarajah, J. R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.028 · Cited by 417
Mechanisms of NOD-like Receptor-Associated Inflammasome Activation
Wen, H., Miao, E. A., & Ting, J. P.-Y. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.037 · Cited by 415
Role of the Immune System in Hypertension
Rodriguez-Iturbe, B., Pons, H., & Johnson, R. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2016 · Cited by 391
“The priming of NLRP3 is a requisite for inflammasome activation except when there is constitutive NLRP3 expression, as in macrophages (10, 11).”
BackgroundThe Acute Respiratory Distress Syndrome: From Mechanism to Translation
Han, S., & Mallampalli, R. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402513 · Cited by 391
“Antioxidants (72) and glyburide (73) block upstream signaling of the NLRP3 inflammasome in vitro.”
BackgroundTargeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Doyle, S., Ozaki, E., & Campbell, M. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s51250 · Cited by 380
“Basal expression of the precursor proform of IL-1β as well as the NLRP3 protein is barely detectable, so a priming step or “signal 1” is required to drive their transcription.(23) This is usually facilitated through activation of Toll-like receptors or NOD2 to initiate the nuclear factor kappa B (NF-κB) signaling path…”
de Zoete, M. R., Palm, N. W., Zhu, S., & Flavell, R. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016287 · Cited by 379
“In addition, although ROS inhibitors were shown to inhibit NLRP3 activation, this effect was likely because of the role of ROS in NF-kB mediated up-regulation of NLRP3 and pro-IL-1b transcription (signal one) rather than its role in NLRP3 inflammasome activation itself (Bauernfeind et al. 2011).”
BackgroundRedox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
“However, when Nrf2 is exogenously activated in a COPD mouse model by sulforaphane or an imidazole derivative of 2-cyano3,12-dioxooleana-1,9(11)-dien-28-oic acid, lung emphysema is clearly reduced (181, 277).”
BackgroundTRPM2 links oxidative stress to NLRP3 inflammasome activation
Zhong, Z., Zhai, Y., Liang, S., Mori, Y., Han, R., Sutterwala, F. S., & Qiao, L. (2013) · Nature Communications · doi:10.1038/ncomms2608 · Cited by 375
Baker, P. J., Boucher, D., Bierschenk, D., Tebartz, C., Whitney, P. G., D'Silva, D. B., Tanzer, M. C., Monteleone, M., Robertson, A. A. B., Cooper, M. A., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545655 · Cited by 366
Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation
Wang, Y., Shi, P., Chen, Q., Huang, Z., Zou, D., Zhang, J., Gao, X., & Lin, Z. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz020 · Cited by 362
“The list of Nlrp3 inflammasome activators continues to grow, although the detailed mechanisms by which Nlrp3 senses several different activators are not yet fully understood (Hornung et al., 2008; Bauernfeind et al., 2011).”
BackgroundMan, S. M., Karki, R., & Kanneganti, T. (2016) · European Journal of Immunology · doi:10.1002/eji.201545839 · Cited by 354
Hemolysis-induced lethality involves inflammasome activation by heme
Dutra, F. F., Alves, L. S., Rodrigues, D., Fernandez, P. L., de Oliveira, R. B., Golenbock, D. T., Zamboni, D. S., & Bozza, M. T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405023111 · Cited by 353
“It was suggested that inhibitors of ROS block the priming of macrophages, impairing the pro–IL-1β and NLRP3 expression instead of affecting the NLRP3 activation (51).”
BackgroundThe NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 348
Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
Grailer, J. J., Canning, B. A., Kalbitz, M., Haggadone, M. D., Dhond, R. M., Andjelkovic, A. V., Zetoune, F. S., & Ward, P. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400368 · Cited by 337
Pathogenesis of acute stroke and the role of inflammasomes
Fann, D. Y.-W., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 335
Kelly, B., Tannahill, G. M., Murphy, M. P., & O'Neill, L. A. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662114 · Cited by 334
“ROS have been implicated in LPS-induced IL-1 mRNA production in macrophages (14).”
BackgroundImmunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Fann, D. Y.-W., Lim, Y.-A., Cheng, Y.-L., Lok, K.-Z., Chunduri, P., Baik, S.-H., Drummond, G. R., Dheen, S. T., Sobey, C. G., Jo, D.-G., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0394-9 · Cited by 309
Salminen, A., Ojala, J., Kaarniranta, K., & Kauppinen, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0962-0 · Cited by 302
“[70] demonstrated that the ROS-induced activation of NLRP3 was clearly attributable to the priming process, since ROS inhibitors blocked the priming step in NLRP3 activation.”
BackgroundThe NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases
Sayan, M., & Mossman, B. T. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0162-4 · Cited by 296
“Subsequently it was demonstrated that ROS were required for priming but unnecessary for activation [17].”
BackgroundNLRP3 at the interface of metabolism and inflammation
Haneklaus, M., & O'Neill, L. A. J. (2015) · Immunological Reviews · doi:10.1111/imr.12285 · Cited by 294
“On the other hand, other studies found that mitochondrial damage and ROS are dispensable for NLRP3 activation (58, 59).”
BackgroundTargeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
Karunakaran, D., Geoffrion, M., Wei, L., Gan, W., Richards, L., Shangari, P., DeKemp, E. M., Beanlands, R. A., Perisic, L., Maegdefessel, L., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600224 · Cited by 293
DAMPs as mediators of sterile inflammation in aging-related pathologies
Feldman, N., Rotter-Maskowitz, A., & Okun, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.003 · Cited by 283
“…1 and 2 (Bauernfeind et al., 2009; Fettelschoss t al., 2011; Franchi et al., 2009; Gross et al., 2012; Gu et al., 997; Keller et al., 2008; Latz et al., 2013; Thornberry et al., 1992; illingham et al., 2009) as well as the production of reactive oxyen species (ROS) (Bauernfeind et al., 2011) (Fig.”
BackgroundIchinohe, T., Yamazaki, T., Koshiba, T., & Yanagi, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312571110 · Cited by 283
“37 (KDa) EGFP UCP-2 (full) UCP-2 (1-200) pro-IL-1β + – – + – + – + – – + + pro-IL-1β Actin 50 HEK293T D”
BackgroundInfluentialNOD-Like Receptors: Master Regulators of Inflammation and Cancer
Saxena, M., & Yeretssian, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00327 · Cited by 274
“It is noteworthy that a transcriptionally silent mechanism for TLR4-mediated inflammasome priming has been lately discovered (153, 154).”
BackgroundVimentin regulates activation of the NLRP3 inflammasome
dos Santos, G., Rogel, M. R., Baker, M. A., Troken, J. R., Urich, D., Morales-Nebreda, L., Sennello, J. A., Kutuzov, M. A., Sitikov, A., Davis, J. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7574 · Cited by 274
Oxidative stress and the ageing endocrine system
Vitale, G., Salvioli, S., & Franceschi, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.29 · Cited by 270
Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation
Orlowski, G. M., Colbert, J. D., Sharma, S., Bogyo, M., Robertson, S. A., & Rock, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500509 · Cited by 268
“In fact, a recent paper emphasized this point by demonstrating that several ROS inhibitors thought to suppress NLRP3 activation actually affect Signal 1 (15).”
BackgroundSpotlight on the NLRP3 inflammasome pathway
Groslambert, M., & Py, B. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s141220 · Cited by 263
Simard, J.-C., Cesaro, A., Chapeton-Montes, J., Tardif, M., Antoine, F., Girard, D., & Tessier, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072138 · Cited by 262
“Signals triggering formation and activation of the inflammasome involve decreased intracellular K and the generation of oxidative stress [27,49,50].”
BackgroundMolecular mechanisms of gasdermin D pore-forming activity
Devant, P., & Kagan, J. C. (2023) · Nature Immunology · doi:10.1038/s41590-023-01526-w · Cited by 258
Liu, X., Zhang, X., Ding, Y., Zhou, W., Tao, L., Lu, P., Wang, Y., & Hu, R. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6615 · Cited by 257
Herzner, A.-M., Hagmann, C. A., Goldeck, M., Wolter, S., Kübler, K., Wittmann, S., Gramberg, T., Andreeva, L., Hopfner, K.-P., Mertens, C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3267 · Cited by 256
Self-citationRole of the Inflammasome, IL-1β, and IL-18 in Bacterial Infections
Sahoo, M., Ceballos-Olvera, I., del Barrio, L., & Re, F. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/212680 · Cited by 256
Inflammasome: Its role in traumatic brain and spinal cord injury
Mortezaee, K., Khanlarkhani, N., Beyer, C., & Zendedel, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26287 · Cited by 251
Neuroinflammation in animal models of traumatic brain injury
Chiu, C.-C., Liao, Y.-E., Yang, L.-Y., Wang, J.-Y., Tweedie, D., Karnati, H. K., Greig, N. H., & Wang, J.-Y. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.06.018 · Cited by 248
“Recently, increases in reactive oxygen species (ROS) generation were found to be a key factor to activate NLRP3 inflammasomes (Bauernfeind et al., 2011).”
BackgroundThe NLRP3 Inflammasome in Alzheimer’s Disease
Tan, M.-S., Yu, J.-T., Jiang, T., Zhu, X.-C., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8475-x · Cited by 248
“Concurrently, some studies implicated mitochondrial ROS in the NF-κBmediated upregulation of NLRP3 and proIL-1β transcripts rather than in NLRP3 inflammasome activation per se [21].”
BackgroundHow location and cellular signaling combine to activate the NLRP3 inflammasome
Akbal, A., Dernst, A., Lovotti, M., Mangan, M. S. J., McManus, R. M., & Latz, E. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00922-w · Cited by 247
“Indeed, preliminary studies suggest that antioxidants inhibit NLRP3 priming rather than NLRP3 activation [37].”
BackgroundSegovia, J., Sabbah, A., Mgbemena, V., Tsai, S.-Y., Chang, T.-H., Berton, M. T., Morris, I. R., Allen, I. C., Ting, J. P.-Y., & Bose, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029695 · Cited by 244
Inflammasome Priming in Sterile Inflammatory Disease
Patel, M. N., Carroll, R. G., Galván-Peña, S., Mills, E. L., Olden, R., Triantafilou, M., Wolf, A. I., Bryant, C. E., Triantafilou, K., & Masters, S. L. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.007 · Cited by 241
Intestinal mucus components and secretion mechanisms: what we do and do not know
Song, C., Chai, Z., Chen, S., Zhang, H., Zhang, X., & Zhou, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00960-y · Cited by 237
Parajuli, B., Sonobe, Y., Horiuchi, H., Takeuchi, H., Mizuno, T., & Suzumura, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.503 · Cited by 232
“High concentrations of ROS inhibitors are reported to block NF-kB-mediated by priming of NLRP3 inflammasome.(29) We treated microglia with N-acetylcysteine (NAC), a potent ROS scavenger, for 30 min after LPS priming and before the addition of oAb.”
MethodThe NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
O’Brien, W. T., Pham, L., Symons, G. F., Monif, M., Shultz, S. R., & McDonald, S. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01778-5 · Cited by 222
Chang, Y.-P., Ka, S.-M., Hsu, W.-H., Chen, A., Chao, L. K., Lin, C.-C., Hsieh, C.-C., Chen, M.-C., Chiu, H.-W., Ho, C.-L., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24903 · Cited by 216
“…reduces caspase-1-dependent pyroptosis Pyroptosis is a type of caspase-1-dependent cell death characterized by a loss of membrane integrity that results from caspase-1-dependent insertion of a pore into the membrane, leading to fluid influx, cell swelling, and lysis (Bergsbaken et al., 2009).”
BackgroundIL‐1β and IL‐18: inflammatory markers or mediators of hypertension?
Krishnan, S. M., Sobey, C. G., Latz, E., Mansell, A., & Drummond, G. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12876 · Cited by 215
“Statins (3-hydroxy-3-methylglutaryl-coenzyme A [HMGCoA] reductase inhibitors) are widely used in the clinic to reduce serum cholesterol levels – and thus cardiovascular risk – in patients with hypercholesterolaemia (Sirtori, 2014).”
BackgroundThe Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Liang, T., Zhang, Y., Wu, S., Chen, Q., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845185 · Cited by 213
“Bauernfeind and his colleagues also showed that ROS inhibitors only blocked the priming step of NLRP3 inflammasome activation, while its direct activation step was not affected, which implied that the role of ROS was limited to the priming step of NLRP3 activation (Bauernfeind et al., 2011).”
BackgroundHonda, H., Nagai, Y., Matsunaga, T., Okamoto, N., Watanabe, Y., Tsuneyama, K., Hayashi, H., Fujii, I., Ikutani, M., Hirai, Y., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0114-005rr · Cited by 211
“Another study suggested that ROS inhibitors blocked NLRP3 inflammasome activation by interfering with the priming step that is required to induce NLRP3 expression, whereas direct NLRP3 activation was not affected [51].”
BackgroundRedox Regulation of Inflammation: Old Elements, a New Story
Lei, Y., Wang, K., Deng, L., Chen, Y., Nice, E. C., & Huang, C. (2015) · Medicinal Research Reviews · doi:10.1002/med.21330 · Cited by 209
New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
De Nardo, D., De Nardo, C. M., & Latz, E. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.007 · Cited by 205
“The precise role of ROS remains somewhat controversial, because ROS may be required only during the transcriptional priming step, rather than for post-translational NLRP3 activation itself.(24)”
BackgroundMitochondria and the NLRP3 inflammasome: physiological and pathological relevance
Yu, J.-W., & Lee, M.-S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0827-4 · Cited by 205
Bordt, E. A., & Polster, B. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.033 · Cited by 202
“of ROS in NLRP3 inflammasome activation [128] or suggested that ROS are necessary only for an LPS “priming” step involving induction of NLRP3 and pro-IL-1β protein expression, but not for actual NLRP3-dependent caspase-1 activation [129].”
NOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 201
“dependent priming signal [98].”
BackgroundInfluentialNLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes
Boaru, S. G., Borkham-Kamphorst, E., Van de Leur, E., Lehnen, E., Liedtke, C., & Weiskirchen, R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.029 · Cited by 201
Encephalomyocarditis Virus Viroporin 2B Activates NLRP3 Inflammasome
Ito, M., Yanagi, Y., & Ichinohe, T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002857 · Cited by 198
“This is consistent with a previous report showing that CHX dose not inhibit nigericininduced NLRP3 activation in primed macrophages [21].”
Result
Metadata
- Authors
- Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., & Hornung, V.
- Affiliations
- University of Bonn (DE)
- University of Michigan (US)
- Corresponding author
- Bauernfeind, Franz
- Bartok, Eva
- Rieger, Anna
- Hornung, Veit
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07
- Volume
- 187
- Issue
- 2
- Pages
- 613-617
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3131480
- OpenAlex
- W1756750202
- Cited by
- 617
- References
- 25
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 41 · 2023: 32 · 2022: 43 · 2021: 32 · 2020: 48 · 2019: 36 · 2018: 41 · 2017: 26 · 2016: 41 · 2015: 50 · 2014: 46 · 2013: 70 · 2012: 45
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Takeda Oncology
- National Institute of Allergy and Infectious Diseases (R01AI063331)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091191)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- NLRP3 inflammasome, reactive oxygen species, inflammasome priming, inflammasome activation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, NADPH Oxidase 2, Animals, Biphenyl Compounds, Carrier Proteins, Cells, Cultured, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Mutant Strains, Onium Compounds, Signal Transduction, Down-Regulation, Reactive Oxygen Species, NADPH Oxidases, STAT1 Transcription Factor, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.